Attending the GLP-1-Based Therapeutics Summit? Meet the ICON team to learn about our proven success designing and executing early phase studies, supported by a robust database of overweight/obese healthy volunteers and...

On 15 April at 12:00 pm, join ICON’s Alan Baldridge at the GLP-1-Based Therapeutics Summit where he will be speaking on “Is there anything GLP‑1s can’t do? Unlocking the next generation of metabolic treatments.” He’ll c...

Latest issue out now. Do you struggle to keep on top of regulatory changes affecting the world of medicine and medical device clinical trials? Join thousands of subscribers who have discovered the convenience of our ...

ICON’s Patient Centred Outcomes team advanced key research in 2025, with over 45 highly experienced specialists supporting programmes across major therapy areas. With twelve peer‑reviewed papers, two educational events...

ICON is pleased to participate in the upcoming PharmaSUG India Single Day Event, taking place on 11 April at the Eli Lilly office in Bangalore. Madhan Kumar, Statistical Programmer II, will deliver a presentation titled...

At the PharmaSUG India Single Day Event on 11 April, hosted at the Eli Lilly office in Bangalore, ICON will be represented by Gomathi S, Statistical Programmer I. Gomathi will present the poster titled “Evolving submiss...

Today \@WVCUS, join ICON plc experts for a working group discussion on ‘Vaccine trials: How AI shifts execution from static plans to living systems’. Learn more at 11:40 am: https://ow.ly/9Uk050Yr8VL

Join ICON at World Vaccine Congress 2026 as we share our latest insights in HIV vaccine and therapeutic development. With 30+ HIV studies, 13,800+ participants, and 20+ years of operational experience across 27 African a...

Meet with ICON experts at the GLP-1-Based Therapeutics Summit to gain valuable insights on obesity clinical development and learn about our ready-to-deploy infrastructure designed to accelerate obesity and comorbidity pr...

Earlier this month, our teams across ICON came together around the world to celebrate International Women’s Day. From team celebrations and office events to shared moments of reflection, this year’s theme, Give to Gain,...

Accellacare, ICON’s clinical research network, offers a wide range of stand-alone and integrated solutions to increase patient access to innovative treatments. Meet us at #WorldVaccineCongress, booth 222 to learn how o...

Deepali Suri, President of ICON Biotech, has been published in Pharmaceutical Executive. Her article draws on insights from 163 biotech leaders across North America, EMEA and APAC, supported by a supplementary survey o...